PSG Consensus Statement on management of Hepatitis C Virus Infection - 2003

Journal of the Pakistan Medical Association

Volumn 54, Issue 3, 2004, Pages 146-150

  Hamid, S ^a   Umar, M ^b   Alam, A ^b   Siddiqui, A ^b   Qureshi, H ^b   Butt, J ^b  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS ANTIBODY; VIRUS RNA;

BLOOD DONOR; CHRONIC LIVER DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; METHODOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PAKISTAN; POLYETHYLENE GLYCOLS;

EID: 1942534187     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Kuo G, Choo QL, Alter H, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
2. Brown RS, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transplantation 2003;9 (Suppl 3):S10-13.
3. Armstrong GL, Alter MJ, McQuillan GM, et al. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-82.
4. NIH Consensus statement: management of hepatitis C. Hepatology 2002:36 (Suppl 1):S1-20.
5. Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001;49 (Suppl l):i1-i12.
6. Farrell GC, Liaw YF. Towards a consensus on the control of chronic hepatitis B and hepatitis C in the Asia-Pacific region. J Gastro Hepatol 2000;15:E1-E2.
7. Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997;119:349-56.
8. Aslam M, Aslam J. Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001;33:407-11.
9. Zuberi SJ. International Hepatology Communications 1996;5:19-26.
10. Kakepoto GN, Bhally HS, Khaliq G, et al. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996;27:703-6.
11. Mujeeb SA, Khan M. Prevalence of HBV, HCV and HIV infections among family blood donors. Saudi Med J 1996;16:702-3.
12. Kazmi K, Sadruddin A, Dil AS, et al. Prevalence of HCV in blood donors. Pak J Med Res 1997;36:61-2.
13. Lone DS, Aman S, Aslam M. Prevalence of hepatitis C antibody in blood donors of Lahore. Biomedica 1999;15:103-7.
14. Malik IA, Ahmed N, Luqman M, et al. Hepatitis C as a cause of chronic liver disease in Northern Pakistan. JPMA 1992;42:67-8.
15. Khan AA, Rehman K, Haider Z, et al. Seromarkers of hepatitis B and C in Pakistan with cirrhosis. J Coll Physicians and Surg Pak 2002;12:105-7.
16. Umar M, Khaar HB, Anwar F, et al. The management of acute variceal bleeding by octreotide. JRMC 2000;4:14-16.
17. Hamid S, Tabbasum S, Jafri W, et al. Hepatitis C has replaced Hepatitis B as the major cause of chronic liver disease in Pakistan. Hepatology 1999;30:212A.
18. Chohan AR, Umar M, Khaar B. Demographic features of hepatocellular carcinoma. A study of 30 cases. JRMC 2001;5:81-3.
19. Luby S, Khanani R, Zia M, et al. Evalaution of blood bank practices in Karachi, Pakistan and the goverment's response. Health Policy Plan 2000;15:217-22.
20. Khan AJ, Luby SP, Fikree F, et al. Unsafe injections and the transmission hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000;78:956-63.
21. Bari A, Akhtar S, Rahbar MH, et al. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health. 2001;6:732-8.
22. Moatter T, Hussainy AS, Hamid S, et al. Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3. Int J Infect Dis 2002;6:272-6.
23. Khokhar N, Asif N, Khokhar OS. Serotype 3 is most common hepatitis C serotype in Pakistan: however, significant numbers are untypeable. Hepatology 2003;38:270-1.
24. Courouce AM, Le Marrec N, Girault A, et al. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion. 1994;34:790-5.
25. Saadeh S, Cammel G, Carey WD, et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001;33:196-200.
26. Heathcote EJ, Shiffman ML, Cooksley WGE, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000;343:1673-80.
27. Teuber G, Pascu M, Berg T, et al. Randomized, controlled trial with IFN-alfa combined with ribavirin with and without amantidine sulphate in non-responders with chronic hepatitis C. J Hepatology 2003;39:606-13.